nbi 27914 has been researched along with Pain, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, T; Arakaki, S; Asaoka, Y; Hara, R; Kimura, K; Minami, M; Nomura, H; Sakasai, K; Suzuki, H; Takahashi, D; Yamauchi, N | 1 |
| Amano, T; Asaoka, Y; Hara, R; Minami, M; Nomura, H; Takahashi, D | 1 |
2 other study(ies) available for nbi 27914 and Pain, Chronic
| Article | Year |
|---|---|
Tonic Suppression of the Mesolimbic Dopaminergic System by Enhanced Corticotropin-Releasing Factor Signaling Within the Bed Nucleus of the Stria Terminalis in Chronic Pain Model Rats.
Topics: Aniline Compounds; Animals; Chronic Pain; Corticotropin-Releasing Hormone; Disease Models, Animal; Dopaminergic Neurons; Male; Patch-Clamp Techniques; Pyrimidines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Signal Transduction; Ventral Tegmental Area | 2019 |
Disappearance of the inhibitory effect of neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in rats with chronic pain.
Topics: Aniline Compounds; Animals; Chronic Pain; Corticotropin-Releasing Hormone; Male; Membrane Potentials; Neurons; Neuropeptide Y; Nucleus Accumbens; Pyrimidines; Rats, Sprague-Dawley; Septal Nuclei | 2020 |